Summary: In a series of 156 thyrotoxic patients treated with low doses of radioactive iodine the therapeutic dose was calculated by means of a sliding scale in which the dose level was varied according to the estimated size of the gland. Of the patients so treated 56.5% achieved a remission with a single dose of 13II. The incidence of hypothyroidism at one year was 5%.
Introduction
One serious disadvantage of 13 I therapy is the rising incidence of hypothyroidism with the passage of time. Beling and Einhorn (1961) first drew attention to this complication, and further reports have confirmed their original findings (Dunn and Chapman, 1964; Green and Wilson, 1964 ; McGirr et al., 1964; Greig et al., 1966; Nofal et al., 1966) . Smith and Wilson (1967) showed that the incidence of hypothyroidism could be reduced by giving a smaller radiation dose to the thyroid. The lower radiation dose resulted in a higher proportion of patients who were still hyperthyroid after treatment, and these patients required additional treatment with an antithyroid drug. A substantial proportion of them subsequently achieved a remission on the antithyroid drug, which could then be discontinued. We adopted a somewhat similar scheme of treatment in 1965.
Methods

Preliminary Treatment with Antithyroid Drug
PAients other than those with relatively mild thyrotoxicosis were given preliminary treatment with carbimazole for a period of 6 to 12 weeks. Pretreatment with this drug does not modify the response of thyrotoxic patients to subsequent treatment with "31I . Some patients from other hospitals had been maintained on an antithyroid drug for longer periods by the time they were referred for treatment. The antithyroid drug was discontinued 48 hours before a pretherapeutic test dose of 131I was given. All patients selected for '"HI therapy, including those with recurrent hyperthyroidism after thyroidectomy, were treated with a single dose of 131I.
The interval between stopping treatment with carbimazole and giving the therapeutic dose of 131I was from three to five days.
Calculation of Dose
The therapeutic dose was based on the 24-hour uptake following a test dose of 131I and the size of the gland estimated by palpation. The dose was calculated by means of a sliding scale in which the dose level was varied according to the size of the gland (see Table) An incidence of hypothyroidism of 5% at one year is probably acceptable, and it would seem impracticable to attempt to reduce it any further. The natural history of the diseas suggests that a certain incidence of hypothyroidism is to be expected with any method of treatment, and the incidence after surgery is probably rather higher than is generally realized. Hedley et at. (1969) , for instance, traced 150 patients treated surgically for thyrotoxicosis between 1946 and 1965, and found the total incidence of hypothyroidism to be 38%. Nofal et al. (1966) estimated that 43% of surgically treated patients would become hypothyroid within 10 years of treatment.
Treatment for the patients who were still hyperthyroid after 13'I and two courses of treatment with carbimazole has clearly been unsatisfactory. In retrospect some alternative plan would have been preferable, but we cannot yet identify this small proportion of patients, about 10% of the total number treated, who eventually proved to be unresponsive to the combined method of treatment.
Hagen et al. (1967) compared high-and low-dosage levels in a series of thyrotoxic patients. In the low-dosage group, who were given a dose of 80 /iCi 3 II per estimated gremme of thyroid tissue, the incidence of hypothyroidism after a mean follow-up period of 19 months was 6%. Our results with regard to the incidence of hypothyroidism are similar to those of Smith and Wilson (1967) . They reduced the incidence of hypothyroidism to 4-3% in a group of patients given a radiation dose of 3,500 rads, though at this dosage level 65% of the patients were still toxic after one treatment. The cumulative incidence of hypothyroidism in their patients was 7-4% at five years. We are not able at this stage to estimate the cumulative incidence of hypothyroidism in the patients we have treated with low doses of radioactive iodine.
Conclusions
The method of treatment described here has effectively reduced the initial incidence of hypothyroidism. A dosage scheme in which the dosage level is related to thyroid size is probably more appropriate than a uniform dose level for all patients.
Introduction
One disadvantage of 131I therapy for thyrotoxicosis, particularly when low doses are used, is that the therapeutic effect is rather slow. In patients with severe thyrotoxicosis it is often desirable to control the disease as quickly as possible by means of an antithyroid drug. The remission rate, however, as judged by the proportion of patients who were cured by one dose of 131I, was lower in patients who had been previously treated with methylthiouracil (Crooks et al., 1960) . It was concluded from these findings that pretreatment with methylthiouracil rendered the gland relatively radioresistant. Similar observations have been made in the case of propylthiouracil (Einhorn and Siterborg, 1962) . For a number of years we had been using carbimazole to control thyrotoxicosis before 131I therapy and it seemed advisable to find out whether this drug had a similar effect. The effect of pretreatment with carbimazole was accordingly investigated in patients who had been treated with 13'I for thyrotoxicosis between 1960 
Methods
Patients selected for 13 1I therapy were divided into two groups according to whether or not they were given preliminary
